Skip to main content

Table 3 Statistical analysis of pretreatment hemoglobin parameters with tumor pathological variables a

From: Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria

  tHb oxyHb deoxyHb Tumor type NS MC/10 hpf Triple-negative HER2 ER
tHb   0.841 0.637 0.166 0.430 0.206 0.108 0.144 0.312
P < 0.001 P < 0.001 P = 0.333 P = 0.009 P = 0.229 P = 0.532 P = 0.404 P = 0.064
oxyHb    0.302 0.066 0.234 0.005 0.115 0.108 0.330
P = 0.074 P = 0.703 P = 0.170 P = 0.979 P = 0.505 P = 0.532 P = 0.049
deoxyHb     0.050 0.356 0.292 0.093 0.086 0.275
P = 0.771 P = 0.033 P = 0.084 P = 0.589 P = 0.618 P = 0.105
  1. adeoxyHb, Deoxygenated hemoglobin; ER, Estrogen receptor; HER2, Human epidermal growth factor receptor 2; hpf, High-power field; MC, Mitotic count; NS, Nottingham score; oxyHb, Oxygenated hemoglobin; tHb, Total hemoglobin.